SITC's Guide to Managing Immunotherapy Toxicity (Record no. 42295)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01857cam a2200253 4500 |
| 001 - CONTROL NUMBER | |
| control field | 0826172148 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200608t2019 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0826172148 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780826172143 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ernstoff, Marc (ed) |
| 245 #0 - TITLE STATEMENT | |
| Title | SITC's Guide to Managing Immunotherapy Toxicity |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | United States : |
| Name of publisher, distributor, etc. | Springer, |
| Date of publication, distribution, etc. | 2019 |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Overview of Anti-CLA-4 agents - ipilimunab and tremelimumab; Overview of PD-1 and PD-L1 inhibitors; Indication and toxicities of immune checkpoint inhibitor combinations; General principles of immune-related toxicities; Dermatologic toxicities - rash, mucosal irritation, and pruritus; Muskuloskeletal and rheumatologic toxicities; Immune-related gastrointestinal toxicities; Pneumotoxicity associated with immune checkpoint blockades; Immune-related endocrinopathies associated with immune checkpoint inhibitors; Neurologic adverse events and neurologic complications; Cardiovascular toxicities related to immune checkpoint inhibitors; Renal toxicities associated with immune checkpoint inhibitors; Haematologic toxicities of apparent immune-related origins; Ocular toxicities caused by immune dysregulation; Safety and regulation of immune checkpoint inhibitors in special patient populations; Cancer-related fatigue in patients of immune checkpoint inhibitor therapy; Cost-effectiveness and financial toxicity of new cancer therapies |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | SITC's Guide to Managing Immunotherapy Toxicity is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Immunotherapy |
| 9 (RLIN) | 6577 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology |
| 9 (RLIN) | 13364 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Immunotherapy |
| 9 (RLIN) | 6577 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Oncology |
| 9 (RLIN) | 13364 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Puzanov, Igor (ed) |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Robert, Caroline (ed) |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Diab, Adi (ed) |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hersey, Peter (ed) |
| Withdrawn status | Lost status | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| David Adams Library (Royal Marsden) | David Adams Library (Royal Marsden) | Shelves | 07/07/2021 | QZ200 ERN | 0000007682 | 07/07/2021 | 07/07/2021 | Book |